NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/02/2025
Voltar para busca
Dado oficial do USPTO
OXFORD BIOMEDICA SOLUTIONS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
OXFORD BIOMEDICA SOLUTIONS
ST13
US500000097361222Classe
5, 40, 42, 44, 45
Pedido
97361222
Registro
7683508
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
11/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 40, 42, 44, 45
Data de depósito
13/04/2022
Data de registro
11/02/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/02/2025
Última transação
11/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
11
Localização do titular
Oxford, GB
Examinador
HAYES, GINA CLARK
Unidade examinadora
L30
Localização atual
INTENT TO USE SECTION
Titulares e representantes
Titulares
Oxford BioMedica Plc
Representantes
Roberta S. Bren MUNCY, GEISSLER, OLDS & LOWE, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationsbiological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseasesvaccines; pharmaceutical substances and preparations for the treatment or prevention of cancerinfectious diseasefungal diseasesdisease caused by bacteriaviruses and parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasesinherited diseasesingle gene disordersdiseases of the mouthteethskinhair and earbone and blood diseases and reproductive system disorders; gene therapy productsnanoparticlesviral vectorsretroviral vectorslentiviral vectors and non-viral vectors for the delivery of genes to cellsall for medical purposes; vaccine manufacturing preparations; viral vaccinesviral vectorretroviral vectorlentiviral vector and non-viral vector preparations for the treatment or prevention of cancerinfectious diseasefungal diseasesdisease caused by bacteriaviruses and parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasesinherited diseasesingle gene disordersdiseases of the mouthteethskinhair and earbone and blood diseases and reproductive system disorders; biochemical and chemical products for use in medical scienceviral vectors; pharmaceutical and biochemical preparations for the treatment or prevention of cancerinfectious diseasefungal diseasesdisease caused by parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasesinherited diseasesingle gene disordersdiseases of the mouthteethskinhair and earbone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes
Classe 40
Custom manufacture of products relating to biotechnology; manufacture of gene therapyviralretrovirallentiviral and non-viral preparations and biopharmaceutical products; manufacture of biotechnology products; manufacture of viral and non-viral vectors; manufacture of vaccines
Classe 42
Scientific research and development services in the field of biochemistry and genetic engineering; biochemistry engineering; genetic engineering; design of manufacturing facilities; quality control for others; scientific and technological servicestesting and validation services in the fields of gene and cell therapy and biotechnology; product development consultancy in the field of nanotechnologygene therapy and vector-based delivery systems; medical and scientific laboratory services; scientific and technological servicesscientific researchdevelopment and analysis in the fields of gene and cell therapy and biotechnology; industrial analysis servicesanalysis of viral vectors and gene therapy products to assure compliance with medical and pharmaceutical industry standards; provision of scientific information in the field of biotechnologygene therapy and cell therapy; research and scientific analysis relating to drug discovery and development for others; scientific research in the nature of conducting clinical trials for others; manufacture of viral vectorsgene therapy and cell therapy products; product and manufacturing process development in the fields of biotechnologygene therapy and cell therapy
Classe 44
Medical diagnostic testing; information relating to pharmaceuticalsbioceuticals and advanced therapy medicinal products; providing medical information to medical professionals in the form of reports in the field of biotechnologygene therapy and cell therapy; consultancyadvice and information in the field of clinical trialshealthcarepharmaceuticals and advanced therapy medicinal products; medical advisory services relating to vaccination regimes; medical advisory services relating to the treatmentrelief and/or prevention of cancerinfectious diseasesfungal diseasesdisease caused by parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasessingle gene disordersdiseases of the mouthteethskinhair and earbone and blood diseasesreproductive system disorderspharmaceutical and biochemical preparations for contraceptive purposesin humans and animals
Classe 45
Preparation and review of reports for regulatory approval of pharmaceuticals and bioceuticals; licensing of intellectual property; regulatory compliance consulting in the field of chemistry manufacturing and controls (CMC) activities
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
17/01/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
24/06/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
24/06/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
26/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/10/2023
PUBO
PUBLISHED FOR OPPOSITION
31/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/09/2023
ALIE
ASSIGNED TO LIE
14/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/02/2023
GNRT
NON-FINAL ACTION E-MAILED
03/02/2023
CNRT
NON-FINAL ACTION WRITTEN
03/02/2023
DOCK
ASSIGNED TO EXAMINER
31/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/04/2022
NWAP
NEW APPLICATION ENTERED
16/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OXFORD BIOMEDICA SOLUTIONS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.